We are live on
!
Find out more
EI
EAM Investors Portfolio holdings
AUM
$866M
1-Year Est. Return
377.14%
This Fund
S&P 500
This Quarter
Est. Return
+48.85%
1 Year Est. Return
+377.14%
3 Year Est. Return
+5,228.32%
5 Year Est. Return
+49,813.17%
10 Year Est. Return
+19,957,666.26%
AUM
$634M
AUM Growth
+$33.5M
(+5.6%)
Cap. Flow
-$90.2M
Cap. Flow
% of AUM
-14.22%
Top 10 Holdings %
Top 10 Hldgs %
8.15%
Holding
413
New
130
Increased
19
Reduced
118
Closed
127
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
LivePerson
LPSN
|
+$4.19M |
| 2 |
NVTR
Nuvectra Corporation Common Stock
NVTR
|
+$4.14M |
| 3 |
TBCH
Turtle Beach Corp
TBCH
|
+$4.13M |
| 4 |
BEAT
BioTelemetry, Inc.
BEAT
|
+$4.07M |
| 5 |
Tactile Systems Technology
TCMD
|
+$4.05M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Nektar Therapeutics
NKTR
|
+$6.81M |
| 2 |
CUTR
Cutera, Inc.
CUTR
|
+$4.92M |
| 3 |
Vericel Corp
VCEL
|
+$4.77M |
| 4 |
ESPR
Esperion Therapeutics
ESPR
|
+$4.75M |
| 5 |
INST
Instructure, Inc.
INST
|
+$4.68M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 27.66% |
| 2 | Technology | 24.9% |
| 3 | Consumer Discretionary | 14.4% |
| 4 | Industrials | 10.81% |
| 5 | Financials | 5.13% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
RCM
176
DELISTED
R1 RCM Inc. Common Stock
RCM
| $1.39M | 0.22% |
159,965
-18,806
| -11% | -$152K |
|
|
CBAY
177
DELISTED
Cymabay Therapeutics
CBAY
| $1.29M | 0.2% |
96,188
-237,549
| -71% | -$2.97M |
|
178
Crocs
CROX
$6.36B
| $1.28M | 0.2% |
72,866
-20,516
| -22% | -$349K |
|
179
Addus HomeCare
ADUS
$2.16B
| $1.25M | 0.2% |
21,824
-2,566
| -11% | -$140K |
|
180
Funko
FNKO
$326M
| $1.24M | 0.2% |
+98,914
| New | +$968K |
|
|
RTEC
181
DELISTED
Rudolph Technologies Inc
RTEC
| $1.21M | 0.19% |
41,016
-4,823
| -11% | -$147K |
|
182
RadNet
RDNT
$5.02B
| $1.19M | 0.19% |
79,447
-9,341
| -11% | -$127K |
|
183
Johnson Outdoors
JOUT
$491M
| $1.17M | 0.18% |
+13,864
| New | +$1.01M |
|
184
Artivion
AORT
$1.3B
| $1.17M | 0.18% |
+41,900
| New | +$1.06M |
|
185
Arrowhead Research
ARWR
$11.9B
| $1.15M | 0.18% |
+84,633
| New | +$791K |
|
186
Perdoceo Education
PRDO
$1.99B
| $1.14M | 0.18% |
70,710
-8,314
| -11% | -$121K |
|
187
NeoGenomics
NEO
$1.96B
| $1.14M | 0.18% |
+87,107
| New | +$959K |
|
188
Immersion
IMMR
$251M
| $1.14M | 0.18% |
+73,491
| New | +$985K |
|
|
PRMW
189
DELISTED
Primo Water Corporation
PRMW
| $1.13M | 0.18% |
+64,811
| New | +$961K |
|
|
MODV
190
DELISTED
ModivCare
MODV
| $1.12M | 0.18% |
+14,315
| New | +$1.07M |
|
191
Upland Software
UPLD
$12.8M
| $1.11M | 0.18% |
3,229
-379
| -11% | -$119K |
|
|
BAND
192
Bandwidth Inc
BAND
$1.26B
| $1.1M | 0.17% |
28,871
-3,395
| -11% | -$120K |
|
193
Kforce
KFRC
$1.02B
| $1.1M | 0.17% |
+31,994
| New | +$1.01M |
|
|
OPTN
194
DELISTED
OptiNose
OPTN
| $1.08M | 0.17% |
+2,578
| New | +$869K |
|
195
Onto Innovation
ONTO
$12.9B
| $1.08M | 0.17% |
+30,477
| New | +$1.04M |
|
|
ASXC
196
DELISTED
Asensus Surgical, Inc.
ASXC
| $1.07M | 0.17% |
+18,908
| New | +$689K |
|
197
Enova International
ENVA
$6.33B
| $1.07M | 0.17% |
29,303
-17,812
| -38% | -$542K |
|
|
XOXO
198
DELISTED
Xo Group Inc
XOXO
| $1.06M | 0.17% |
+33,196
| New | +$927K |
|
|
CRCM
199
DELISTED
CARE.COM, INC.
CRCM
| $1.06M | 0.17% |
50,617
-18,134
| -26% | -$339K |
|
|
QADA
200
DELISTED
QAD Inc.
QADA
| $1.05M | 0.17% |
+20,982
| New | +$1.01M |
|
Similar funds
NEPWA
RWM
MCM
HP
OMG
RB
BGC
ICCFIA
EAM Investors's Q2 2018 Portfolio in Review
As of Q2 2018, EAM Investors held 413 positions worth $634M, up 5.6% from $601M the previous quarter. Its ten largest holdings account for 8.1% of the portfolio.
EAM Investors withdrew a net $90.2M in Q2 2018, closing 127 positions and reducing 118 holdings. Its most notable exit was Nektar Therapeutics, an estimated $6.81M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 28% of assets, down from 32% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, EAM Investors opened a new position in LivePerson worth $4.69M.
- EAM Investors's largest Q2 2018 buy was LivePerson: 14,807 shares worth $4.69M.
- EAM Investors added most to Malibu Boats in Q2 2018, an estimated $3.06M increase.
- EAM Investors's biggest Q2 2018 reduction was Vericel Corp, cutting an estimated $4.77M.
- EAM Investors fully exited Nektar Therapeutics in Q2 2018, selling an estimated $6.81M.
- EAM Investors's ten largest holdings make up 8.1% of its $634M portfolio in Q2 2018.
- EAM Investors opened 130 new positions and closed 127 in Q2 2018.
- EAM Investors's portfolio value rose 5.6% quarter-over-quarter to $634M.
Based on EAM Investors's 13F filing for Q2 2018, filed 3 Aug 2018.